Lacnotuzumab
Product Specifications
CAS Number
1831128-32-5
Target
C-Fms
Related Pathways
Tyrosine Kinase/Adaptors
Purity
0.9936
Bioactivity
Lacnotuzumab (MCS110) is a humanized monoclonal antibody targeting CSF-1, inhibiting the macrophage colony-stimulating factor pathway upstream components, used in retinal disease research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6275501-01 0.2 mL
ASAP3, NT (ASAP3, DDEFL1, UPLC1, Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3, Development and differentiation-enhancing factor-like 1, Protein up-regulated in liver cancer 1) (AP)
Sign In for Pricing
View Details MBS6275501-02 5x 0.2 mL
ASAP3, NT (ASAP3, DDEFL1, UPLC1, Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3, Development and differentiation-enhancing factor-like 1, Protein up-regulated in liver cancer 1) (AP)
Sign In for Pricing
View Details 
135204-HRP 100 µL
VAPA (Vesicle-associated Membrane Protein-associated Protein A, VAMP-associated Protein A, VAMP-A, VAP-A, 33kD VAMP-associated Protein, VAP33, VAP-33, hVAP-33) (HRP)
Sign In for Pricing
View Details 
043206-PE 200 µL
TRGC2, NT (TRGC2, TCRGC2, T-cell receptor gamma-2 chain C region, T-cell receptor gamma chain C region PT-gamma-1/2) (PE) discontinued
Sign In for Pricing
View Details TN5301 1 mg
Qingyangshengenin 3-O-α-L-cymaropyranosyl- (1→4) -β-D-oleandropyranosyl- (1→4) -β-D-cymaropyranosyl- (1→4) -β-D-cymaropyranoside
Sign In for Pricing
View Details MBS1172264-01 0.02 mg (E-Coli)
Recombinant Arabidopsis thaliana F-box protein PP2-B15 (PP2B15)
Sign In for Pricing
View Details